1. Home
  2. CHE
  3. CHE News

Latest Chemed Corp (CHE) News on July 12, 2025

CHE

Argus Research

17 days ago

CHE: Raising target price to $613.00

5 Must-Read Analyst Questions From Chemed’s Q1 Earnings Call
CHE

StockStory

22 days ago

5 Must-Read Analyst Questions From Chemed’s Q1 Earnings Call

1 Cash-Producing Stock Worth Your Attention and 2 to Brush Off
CHE

StockStory

a month ago

1 Cash-Producing Stock Worth Your Attention and 2 to Brush Off

CHE

Argus Research

a month ago

CHE: Lowering target price to $609.00

Senior Health, Home Health & Hospice Stocks Q1 In Review: Chemed (NYSE:CHE) Vs Peers
CHE

StockStory

a month ago

Senior Health, Home Health & Hospice Stocks Q1 In Review: Chemed (NYSE:CHE) Vs Peers

3 Reasons CHE is Risky and 1 Stock to Buy Instead
CHE

StockStory

a month ago

3 Reasons CHE is Risky and 1 Stock to Buy Instead

3 Healthcare Stocks Skating on Thin Ice
CHE

StockStory

a month ago

3 Healthcare Stocks Skating on Thin Ice

AMED or CHE: Which Is the Better Value Stock Right Now?
CHE

Zacks

2 months ago

AMED or CHE: Which Is the Better Value Stock Right Now?

Chemed (CHE) Up 2.7% Since Last Earnings Report: Can It Continue?
CHE

Zacks

2 months ago

Chemed (CHE) Up 2.7% Since Last Earnings Report: Can It Continue?

BrightSpring Health Services (NASDAQ:BTSG) Q1 Earnings: Leading The Senior Health, Home Health & Hospice Pack
CHE

StockStory

2 months ago

BrightSpring Health Services (NASDAQ:BTSG) Q1 Earnings: Leading The Senior Health, Home Health & Hospice Pack

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
CHE

Business Wire

2 months ago

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

CHE

MT Newswires

2 months ago

Chemed Insider Sold Shares Worth $866,985, According to a Recent SEC Filing

Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference
CHE

Business Wire

2 months ago

Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference

The total return for Chemed (NYSE:CHE) investors has risen faster than earnings growth over the last five years
CHE

Simply Wall St.

2 months ago

The total return for Chemed (NYSE:CHE) investors has risen faster than earnings growth over the last five years

CHE

Argus Research

2 months ago

CHE: Lowering target price to $613.00

CHE Q1 Earnings Call: Acquisition-Driven Growth and Medicare Cap Strategy Shape Outlook
CHE

StockStory

2 months ago

CHE Q1 Earnings Call: Acquisition-Driven Growth and Medicare Cap Strategy Shape Outlook

CHE

MT Newswires

2 months ago

Chemed Insider Sold Shares Worth $866,790, According to a Recent SEC Filing

Q1 Earnings Highs And Lows: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
CHE

StockStory

2 months ago

Q1 Earnings Highs And Lows: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks

CHE

Argus Research

2 months ago

CHE: Raising target price to $634.00

CHE

MT Newswires

2 months ago

Chemed Insider Sold Shares Worth $864,675, According to a Recent SEC Filing

Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025
CHE

Business Wire

2 months ago

Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025

OPCH vs. CHE: Which Stock Is the Better Value Option?
CHE

Zacks

2 months ago

OPCH vs. CHE: Which Stock Is the Better Value Option?

3 Cash-Heavy Stocks Skating on Thin Ice
CHE

StockStory

2 months ago

3 Cash-Heavy Stocks Skating on Thin Ice

3 Dawdling Stocks That Concern Us
CHE

StockStory

2 months ago

3 Dawdling Stocks That Concern Us

CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines
CHE

Zacks

3 months ago

CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines

Chemed First Quarter 2025 Earnings: EPS Misses Expectations
CHE

Simply Wall St.

3 months ago

Chemed First Quarter 2025 Earnings: EPS Misses Expectations

CHE

Thomson Reuters StreetEvents

3 months ago

Q1 2025 Chemed Corp Earnings Call

Chemed Corporation (CHE): A Bull Case Theory
CHE

Insider Monkey

3 months ago

Chemed Corporation (CHE): A Bull Case Theory

Chemed (CHE) Surpasses Q1 Earnings and Revenue Estimates
CHE

Zacks

3 months ago

Chemed (CHE) Surpasses Q1 Earnings and Revenue Estimates

CHE

MT Newswires

3 months ago

Chemed Q1 Adjusted Earnings, Revenue Rise

Chemed’s (NYSE:CHE) Q1 Sales Beat Estimates
CHE

StockStory

3 months ago

Chemed’s (NYSE:CHE) Q1 Sales Beat Estimates

CHE

Associated Press Finance

3 months ago

Chemed: Q1 Earnings Snapshot

Chemed Reports First-Quarter 2025 Results
CHE

Business Wire

3 months ago

Chemed Reports First-Quarter 2025 Results

CHE

Argus Research

3 months ago

CHE: Lowering target price to $637.00

Chemed (CHE) Reports Earnings Tomorrow: What To Expect
CHE

StockStory

3 months ago

Chemed (CHE) Reports Earnings Tomorrow: What To Expect

CHE

Argus Research

3 months ago

CHE: Raising target price to $648.00

Q4 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
CHE

StockStory

3 months ago

Q4 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks

OPCH or CHE: Which Is the Better Value Stock Right Now?
CHE

Zacks

3 months ago

OPCH or CHE: Which Is the Better Value Stock Right Now?

Do Chemed's (NYSE:CHE) Earnings Warrant Your Attention?
CHE

Simply Wall St.

3 months ago

Do Chemed's (NYSE:CHE) Earnings Warrant Your Attention?

CHE

Argus Research

3 months ago

CHE: Lowering target price to $629.00

Chemed Corporation (CHE) Shares Retreated by -13% During TimesSquare U.S. FOCUS Growth Strategy’s Holding Period
CHE

Insider Monkey

3 months ago

Chemed Corporation (CHE) Shares Retreated by -13% During TimesSquare U.S. FOCUS Growth Strategy’s Holding Period

Chemed (CHE): Buy, Sell, or Hold Post Q4 Earnings?
CHE

StockStory

3 months ago

Chemed (CHE): Buy, Sell, or Hold Post Q4 Earnings?

CHE

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 04/02/2025

CHE

Argus Research

3 months ago

CHE: Raising target price to $680.00

Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24
CHE

Business Wire

3 months ago

Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24

CHE

MT Newswires

3 months ago

Chemed Insider Sold Shares Worth $615,330, According to a Recent SEC Filing

Why Is Chemed (CHE) Up 4.5% Since Last Earnings Report?
CHE

Zacks

3 months ago

Why Is Chemed (CHE) Up 4.5% Since Last Earnings Report?

CHE

Argus Research

4 months ago

CHE: Rating increased to a BUY

OPCH vs. CHE: Which Stock Is the Better Value Option?
CHE

Zacks

4 months ago

OPCH vs. CHE: Which Stock Is the Better Value Option?

2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off
CHE

StockStory

4 months ago

2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off

Senior Health, Home Health & Hospice Stocks Q4 Teardown: AdaptHealth (NASDAQ:AHCO) Vs The Rest
CHE

StockStory

4 months ago

Senior Health, Home Health & Hospice Stocks Q4 Teardown: AdaptHealth (NASDAQ:AHCO) Vs The Rest

CHE

MT Newswires

4 months ago

Chemed Insider Sold Shares Worth $1,187,340, According to a Recent SEC Filing

Chemed (NYSE:CHE) Might Become A Compounding Machine
CHE

Simply Wall St.

4 months ago

Chemed (NYSE:CHE) Might Become A Compounding Machine

CHE

Argus Research

4 months ago

CHE: Raising target price to $617.00

OPCH or CHE: Which Is the Better Value Stock Right Now?
CHE

Zacks

4 months ago

OPCH or CHE: Which Is the Better Value Stock Right Now?

CHE

MT Newswires

4 months ago

Chemed Insider Sold Shares Worth $785,324, According to a Recent SEC Filing

Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference
CHE

Business Wire

4 months ago

Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference

Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract
CHE

Zacks

4 months ago

Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract

CHE

GuruFocus.com

4 months ago

Chemed Corp (CHE) Q4 2024 Earnings Call Highlights: Strong VITAS Growth Amid Roto-Rooter Challenges

CHE

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Chemed Corp Earnings Call

Chemed (CHE) Surpasses Q4 Earnings and Revenue Estimates
CHE

Zacks

5 months ago

Chemed (CHE) Surpasses Q4 Earnings and Revenue Estimates

CHE

Associated Press Finance

5 months ago

Chemed: Q4 Earnings Snapshot

Chemed’s (NYSE:CHE) Q4: Beats On Revenue
CHE

StockStory

5 months ago

Chemed’s (NYSE:CHE) Q4: Beats On Revenue

CHE

MT Newswires

5 months ago

Chemed Q4 Adjusted Earnings, Revenue Rise; 2025 Outlook Set

Chemed Reports Fourth-Quarter 2024 Results
CHE

Business Wire

5 months ago

Chemed Reports Fourth-Quarter 2024 Results

CHE

Argus Research

5 months ago

CHE: What does Argus have to say about CHE?

What To Expect From Chemed’s (CHE) Q4 Earnings
CHE

StockStory

5 months ago

What To Expect From Chemed’s (CHE) Q4 Earnings

CHE

Argus Research

5 months ago

CHE: Lowering target price to $578.00

Chemed Corporation Declares Quarterly Dividend of 50 Cents
CHE

Business Wire

5 months ago

Chemed Corporation Declares Quarterly Dividend of 50 Cents

Senior Health, Home Health & Hospice Stocks Q3 Results: Benchmarking Brookdale (NYSE:BKD)
CHE

StockStory

5 months ago

Senior Health, Home Health & Hospice Stocks Q3 Results: Benchmarking Brookdale (NYSE:BKD)

Winners And Losers Of Q3: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
CHE

StockStory

5 months ago

Winners And Losers Of Q3: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks

Q3 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
CHE

StockStory

5 months ago

Q3 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks

Senior Health, Home Health & Hospice Stocks Q3 Teardown: The Pennant Group (NASDAQ:PNTG) Vs The Rest
CHE

StockStory

5 months ago

Senior Health, Home Health & Hospice Stocks Q3 Teardown: The Pennant Group (NASDAQ:PNTG) Vs The Rest

ADUS vs. CHE: Which Stock Is the Better Value Option?
CHE

Zacks

5 months ago

ADUS vs. CHE: Which Stock Is the Better Value Option?

Senior Health, Home Health & Hospice Stocks Q3 Earnings Review: Option Care Health (NASDAQ:OPCH) Shines
CHE

StockStory

5 months ago

Senior Health, Home Health & Hospice Stocks Q3 Earnings Review: Option Care Health (NASDAQ:OPCH) Shines

Chemed To Report Fourth-Quarter 2024 Earnings February 26, Related Conference Call To Be Held On February 27
CHE

Business Wire

5 months ago

Chemed To Report Fourth-Quarter 2024 Earnings February 26, Related Conference Call To Be Held On February 27

Senior Health, Home Health & Hospice Stocks Q3 Teardown: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest
CHE

StockStory

5 months ago

Senior Health, Home Health & Hospice Stocks Q3 Teardown: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest

Q3 Earnings Highlights: Addus HomeCare (NASDAQ:ADUS) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks
CHE

StockStory

5 months ago

Q3 Earnings Highlights: Addus HomeCare (NASDAQ:ADUS) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks

Has Chemed Corporation (NYSE:CHE) Stock's Recent Performance Got Anything to Do With Its Financial Health?
CHE

Simply Wall St.

5 months ago

Has Chemed Corporation (NYSE:CHE) Stock's Recent Performance Got Anything to Do With Its Financial Health?

CHE

Argus Research

5 months ago

CHE: Lowering target price to $586.00

Should Investors Hold Chemed Stock in Their Portfolio Now?
CHE

Zacks

5 months ago

Should Investors Hold Chemed Stock in Their Portfolio Now?

CHE

Argus Research

5 months ago

CHE: Raising target price to $589.00

CHE

Argus Research

6 months ago

CHE: Raising target price to $587.00

CHE

Argus Research

6 months ago

CHE: Raising target price to $561.00

Chemed Corporation to Present at the 43rd Annual JPMorgan Healthcare Conference
CHE

Business Wire

6 months ago

Chemed Corporation to Present at the 43rd Annual JPMorgan Healthcare Conference

EHC vs. CHE: Which Stock Should Value Investors Buy Now?
CHE

Zacks

6 months ago

EHC vs. CHE: Which Stock Should Value Investors Buy Now?

Is There An Opportunity With Chemed Corporation's (NYSE:CHE) 31% Undervaluation?
CHE

Simply Wall St.

7 months ago

Is There An Opportunity With Chemed Corporation's (NYSE:CHE) 31% Undervaluation?

CHE

Argus Research

7 months ago

CHE: Lowering target price to $543.00

CHE

Argus Research

7 months ago

CHE: Lowering target price to $551.00

EHC or CHE: Which Is the Better Value Stock Right Now?
CHE

Zacks

7 months ago

EHC or CHE: Which Is the Better Value Stock Right Now?

CHE

Argus Research

7 months ago

CHE: Lowering target price to $575.00

Amedisys (AMED) Down 12.4% Since Last Earnings Report: Can It Rebound?
CHE

Zacks

7 months ago

Amedisys (AMED) Down 12.4% Since Last Earnings Report: Can It Rebound?

CHE

Argus Research

7 months ago

CHE: Lowering target price to $595.00

Chemed Corporation to Present at the BofA Securities 2024 Virtual Home Care Conference
CHE

Business Wire

7 months ago

Chemed Corporation to Present at the BofA Securities 2024 Virtual Home Care Conference

Chemed (NYSE:CHE) shareholders have earned a 6.2% CAGR over the last five years
CHE

Simply Wall St.

7 months ago

Chemed (NYSE:CHE) shareholders have earned a 6.2% CAGR over the last five years

CHE

MT Newswires

7 months ago

Chemed Insider Sold Shares Worth $421,356, According to a Recent SEC Filing

Here’s Why Chemed Corporation (CHE) Rose in Q3
CHE

Insider Monkey

7 months ago

Here’s Why Chemed Corporation (CHE) Rose in Q3

CHE

Argus Research

8 months ago

CHE: Raising target price to $602.00

EHC vs. CHE: Which Stock Is the Better Value Option?
CHE

Zacks

8 months ago

EHC vs. CHE: Which Stock Is the Better Value Option?

CHE

MT Newswires

8 months ago

Chemed Insider Sold Shares Worth $565,710, According to a Recent SEC Filing

Share on Social Networks: